Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population
3 years, 7 months ago

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population

Firstpost  

J&J earlier had sought approval to conduct phase-3 clinical trial of its vaccine on approximately 600 participants in two age groups—those aged 18 and below 60 years and those aged 60 years and above—to evaluate the safety, reactogenicity and immunogenicity of the jab in healthy Indian adults. Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya said on Saturday. Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. In a bid to fast-track emergency approvals for all foreign-produced coronavirus jabs, the central government had announced that COVID-19 vaccines which were approved for restricted use by regulators in the US, UK, Europe and Japan, or which were on the World Health Organisation’s Emergency Use Listing, would not have to conduct bridging clinical trials in India.

India Trial Emergency Johnson 60 Years Approval Vaccine Clinical Clinical Trial Emergency Use Its Vaccine Emergency Use Authorisation  60  covid19  population  aged  india  singledose  clinical  emergency  gets  johnson  johnsons  vaccines  trial  vaccine  approval

History of this topic

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration
6 months, 4 weeks ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC  

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
11 months ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

With State prod, India can be world leader in vaccines
1 year, 2 months ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Covid-19: India reports 441 fresh JN.1 cases; active caseload declines to 3,238
1 year, 2 months ago

Covid-19: India reports 441 fresh JN.1 cases; active caseload declines to 3,238

Firstpost  

India has recorded 441 fresh COVID-19 infections while the number of active cases has come down to 3,238, the Union health ministry said on Saturday. The number of daily cases was in double digits till December 5 but it began to rise again amid cold weather conditions and after the emergence of a new COVID-19 variant, JN.1.After December 5, the …

India logs 756 fresh Covid-19 cases, 5 deaths, 619 JN.1 infections so far
1 year, 2 months ago

India logs 756 fresh Covid-19 cases, 5 deaths, 619 JN.1 infections so far

India Today  

India saw a single-day rise of 756 Covid-19 cases and five deaths in the past 24 hours, the Union Health Ministry said on Sunday. On Saturday, India reported 774 new Covid-19 cases and two deaths from Tamil Nadu and Gujarat, the ministry said. After December 5, the highest single-day rise of 841 cases was reported on December 31, 2023, which …

India logs 602 new Covid cases, 5 deaths; 312 JN.1 cases so far
1 year, 2 months ago

India logs 602 new Covid cases, 5 deaths; 312 JN.1 cases so far

India Today  

India logged 602 fresh Covid cases and five deaths due to the infection in the last 24 hours. A total of 312 cases of coronavirus sub-variant JN.1 were detected in the country until Tuesday, with about 47 per cent of them recorded in Kerala, according to the Indian SARS-CoV-2 Genomics Consortium data. Meanwhile, Karnataka has restarted providing vaccines at its …

India logs 573 new Covid cases, 2 deaths; 263 JN.1 cases so far
1 year, 2 months ago

India logs 573 new Covid cases, 2 deaths; 263 JN.1 cases so far

India Today  

India logged 573 new cases of Covid-19 in the past 24 hours, while the number of active cases of the infection has increased to 4,565, the Union Health Ministry said on Tuesday. The Indian SARS-CoV-2 Genomics Consortium 's data showed 180 Covid cases in the country in December had the presence of JN.1, while 17 such cases were detected in …

LIVE COVID-19 Updates: Delhi Reports First Case of JN.1 Strain; India Sees Single-day Rise of 529 Infections
1 year, 3 months ago

LIVE COVID-19 Updates: Delhi Reports First Case of JN.1 Strain; India Sees Single-day Rise of 529 Infections

News 18  

Karnataka Mandates 7-day Home Isolation for Covid Positive Amidst the uptick in the Covid subvariant JN.1 infection, the Karnataka government declared mandatory 7-day home isolation of positive cases on Wednesday. Covid Cases in India Live Updates: Expert Advises To Wear Mask, Practice Physical Distancing On precautions against JN.1 variant of Covid, Shekhar C Mande, former DG, CSIR says, “People should …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year, 3 months ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year, 3 months ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Covid in India Highlights: Maharashtra reports nine JN.1 infections
1 year, 3 months ago

Covid in India Highlights: Maharashtra reports nine JN.1 infections

Hindustan Times  

Covid in India Highlights: India logged a total of 656 fresh cases of Covid-19 infections on December 24. Former AIIMS, Delhi, director Randeep Guleria said the sub-variant JN.1 is “gradually becoming dominant” but observed that it is not causing severe infections or hospitalisations. The World Health Organisation also classified JN.1 into the Variant of Interest category, however, said there is …

Covid-19 cases rise in India: Existing vaccines protect against new JN.1 sub-variant? What expert says
1 year, 3 months ago

Covid-19 cases rise in India: Existing vaccines protect against new JN.1 sub-variant? What expert says

Live Mint  

Covid 19 cases have started increasing once again in India. JN.1 has extensive resistance across receptor binding domain classes 1, 2, and 3 and shows higher immune evasion as compared with BA 2.86 and other resistant strains. In an interaction with Livemint, Dr. Gurmeet Singh Chabbra, Director-Pulmonary, Marengo Asia Hospitals Faridabad said that according to CDC, vaccines will not block …

COVID-19: No plan to make RT-PCR testing mandatory at airports so far, say Health Ministry sources
1 year, 3 months ago

COVID-19: No plan to make RT-PCR testing mandatory at airports so far, say Health Ministry sources

India TV News  

COVID-19 India update: There is no plan so far to make RT-PCR testing for COVID-19 mandatory at airports for travellers, Union health ministry sources said today, amid an uptick in coronavirus infections in India. Corona infections: India on Thursday recorded 594 fresh COVID-19 infections while the number of active cases increased to 2,669 from 2,311 the previous day, according to …

Centre issues advisory to states amid COVID-19 surge
1 year, 3 months ago

Centre issues advisory to states amid COVID-19 surge

Firstpost  

The central government has asked states to maintain constant vigil over the Covid situation and report and monitor district-wise SARI and ILI cases on a regular basis The Centre on Monday issued advisory to states in view of a recent upsurge in COVID-19 cases and detection of first case of JN.1 variant in India. Centre issues advisory to States in …

Covid subvariant JN.1 case detected in Kerala, authorities keep a vigil
1 year, 3 months ago

Covid subvariant JN.1 case detected in Kerala, authorities keep a vigil

India TV News  

A new Covid subvariiant JN.1 case has been reported in Kerala, raising health authorities' concerns. In Kerala, there are reports of people getting Covid, but the severity so far appears to be the same as before," said Rajeev Jayadev, National Indian Medical Association Covid Task Force's co-chairman. India sees over 300 cases on Saturday India recorded a single-day rise of …

Accelerating Routine Immunization in India: Insights from Covid-19 Drive
1 year, 4 months ago

Accelerating Routine Immunization in India: Insights from Covid-19 Drive

The Quint  

In the aftermath of Covid-19 pandemic and ensuing vaccination drive in India, the country's healthcare system gained invaluable insights into strengthening routine immunization programs. Learnings for Health Sector: The drive provided crucial insights into routine immunization systems, leveraging existing infrastructure and expertise effectively. Role of MOMENTUM Routine Immunization Transformation & Equity Project: National Roll-Out Support: Initiated in August 2021, the …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 9 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 9 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 11 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu  

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

India sees a surge in COVID-19 cases: Does the country need a fourth jab?
1 year, 11 months ago

India sees a surge in COVID-19 cases: Does the country need a fourth jab?

Firstpost  

India has registered 3,641 fresh cases of COVID-19 in the last 24 hours. Experts say taking a booster shot may not be very beneficial COVID-19 cases across several states in India are on the rise, thanks to XXB.1.16 – a subtype of Omicron, also a matter of concern. According to the health ministry data, India logged 3,641 new infections in …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
2 years ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
2 years, 1 month ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine
2 years, 2 months ago

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

Hindustan Times  

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's approval in November for restricted emergency use among adults as a heterologous booster dose. According to a statement issued …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
2 years, 2 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
2 years, 2 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News  

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
2 years, 2 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
2 years, 2 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18  

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
2 years, 2 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years, 3 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years, 3 months ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

Indian Army issues advisory on Covid, asks defence personnel to take safety measures
2 years, 3 months ago

Indian Army issues advisory on Covid, asks defence personnel to take safety measures

India TV News  

The Indian Army issued an advisory on Friday asking defence personnel to take up adequate measures to tackle COVID. The advisory asked them to take up measures such as the usage of face masks in closed or crowded places, practising hand sanitisation, and maintaining social distancing among others. Union Health Minister Dr Mansukh Mandaviya is set to hold a virtual …

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose
2 years, 3 months ago

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose

India TV News  

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose Bharat Biotech nasal vaccine: According to reports, two drops of the vaccine can be treated as a dose. Bharat Biotech's needle-free intranasal Covid vaccine has been approved by the Centre as booster dose for those aged above 18, official sources said. Meanwhile, the Indian Medical Association has advised people to …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years, 3 months ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

Covid-19: Serum Institute seeks drug regulator's approval for market authorisation of Covovax as booster dose
2 years, 3 months ago

Covid-19: Serum Institute seeks drug regulator's approval for market authorisation of Covovax as booster dose

India TV News  

Covid-19: Serum Institute seeks drug regulator's approval for market authorisation of Covovax as booster dose Covid-19: Earlier on October 17, Prakash Kumar Singh, director of government and regulatory affairs at SII, submitted a market authorization application to the Drug Controller General of India for the heterologous booster dose of Covovax. Covid-19: As the threat of coronavirus is far from over, …

COVID-19 vaccine: How well does India’s adverse reaction tracking system work? | In Focus podcast
2 years, 3 months ago

COVID-19 vaccine: How well does India’s adverse reaction tracking system work? | In Focus podcast

The Hindu  

Last month, the Central government, in an affidavit to the Supreme Court, said that it cannot be held liable to pay compensation for deaths caused by adverse reactions to the COVID-19 vaccine. The affidavit was filed in a case in response to a petition filed by the parents of two young women, who allegedly died due to adverse reactions following …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years, 3 months ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

No Wastage of Covid Vaccines in Govt Buffer Stock Due to Expiry: Govt in Lok Sabha
2 years, 3 months ago

No Wastage of Covid Vaccines in Govt Buffer Stock Due to Expiry: Govt in Lok Sabha

News 18  

There has been no wastage of COVID-19 vaccines in the government buffer stock due to expiry, Union minister Bharati Pravin Pawar informed Lok Sabha on Friday. The central government closely monitors COVID-19 vaccine stocks in states and Union territories so as to ensure their optimal utilisation and minimal wastage, Pawar said in written reply to a question. To ensure utilisation …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 4 months ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

COVID-19: India reports 1,542 fresh cases in past 24 hours; Health Minister Mandaviya to review situation
2 years, 5 months ago

COVID-19: India reports 1,542 fresh cases in past 24 hours; Health Minister Mandaviya to review situation

India TV News  

COVID-19: India reports 1,542 fresh cases in past 24 hours; Health Minister Mandaviya to review situation COVID-19 Update: Union Health Minister Mansukh Mandaviya will review the coronavirus situation and the ongoing vaccination drive today. COVID-19 Update: India reported 1,542 fresh Covid positive cases in the past 24 hours which took total active cases to 26,449 with 0.68% positivity rate on …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 5 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

How the COVID-19 pandemic altered the vaccine story in India
2 years, 5 months ago

How the COVID-19 pandemic altered the vaccine story in India

The Hindu  

Last week, Twitter temporarily blocked a post by Florida’s surgeon general Joseph A. Ladapo. Such DNA vaccines, older in provenance than mRNA vaccines, involve inserting DNA for an antigen — or the part of the virus that stimulates the immune system — into a special kind of circular DNA called plasmids that are usually only found in bacteria. In the …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 5 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k
2 years, 6 months ago

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k

Live Mint  

India has witnessed a marginal decline in daily Covid-19 cases on Saturday with country recording 4,912 new infections in the past 24 hours, according to an update given by the Ministry of Health and Family Welfare. The country conducted 3,03,888 Covid tests in the last 24 hours, with the total number of tests conducted so far at 89.33 crore. The …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 6 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

India and China clear needle-free COVID-19 vaccines
2 years, 6 months ago

India and China clear needle-free COVID-19 vaccines

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. CanSino Biologics announced Sunday that Chinese regulators have approved …

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 6 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu  

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use
2 years, 6 months ago

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use

News 18  

Bharat Biotech has been given an emergency use authorisation by India’s drug regulator, the Drug Controller General of India, for its intranasal Covid-19 vaccine, Union Health Minister Dr Mansukh Mandaviya tweeted on Tuesday. Big Boost to India's Fight Against COVID-19!Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted …

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval
2 years, 6 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News  

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

India approves needle-free COVID-19 vaccines. Know all about it
2 years, 6 months ago

India approves needle-free COVID-19 vaccines. Know all about it

India TV News  

India approves needle-free COVID-19 vaccines. CanSino Biologics announced Sunday that Chinese regulators have approved an inhaled version of the company’s injected COVID-19 vaccine to be used as a booster dose. Read: 10 minutes run boosts brain function; know useful benefits of running India’s nasal vaccine was developed by scientists at Washington University in St. Louis and later licensed to Indian …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 7 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

Discover Related